These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7362208)

  • 1. Multisystem triglyceride storage disorder with impaired long-chain fatty acid oxidation.
    Angelini C; Philippart M; Borrone C; Bresolin N; Cantini M; Lucke S
    Ann Neurol; 1980 Jan; 7(1):5-10. PubMed ID: 7362208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic triglyceride storage disease with normal carnitine: a putative defect in long-chain fatty acid metabolism.
    Ibayashi H; Ideguchi H; Harada N; Ishimoto S; Goto I
    J Neurol Sci; 1988 Jun; 85(2):149-59. PubMed ID: 3385431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisystem triglyceride storage disorder without ichthyosis in two siblings.
    Wessalowski R; Schroten H; Neuen-Jacob E; Reichmann H; Melnik BC; Lenard HG; Voit T
    Acta Paediatr; 1994 Jan; 83(1):93-8. PubMed ID: 8193482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake.
    Stanley CA; DeLeeuw S; Coates PM; Vianey-Liaud C; Divry P; Bonnefont JP; Saudubray JM; Haymond M; Trefz FK; Breningstall GN
    Ann Neurol; 1991 Nov; 30(5):709-16. PubMed ID: 1763895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum factors that stimulate fatty acid oxidation: physiological specificity.
    Stanisz J; Wice BM; Kennell DE
    J Cell Physiol; 1986 Jan; 126(1):141-6. PubMed ID: 3944194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid-induced effect on glucagon secretion is mediated via fatty acid oxidation.
    Hong J; Jeppesen PB; Nordentoft I; Hermansen K
    Diabetes Metab Res Rev; 2007 Mar; 23(3):202-10. PubMed ID: 16802400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of impairment of mitochondrial fatty acid beta-oxidation.
    Hasegawa T; Hori N; Du W
    Keio J Med; 2002 Jun; 51(2):100-6. PubMed ID: 12125906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of impaired ketogenesis in fatty acid oxidation disorders.
    Olpin SE
    Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):293-308. PubMed ID: 14769488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
    Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW
    Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary carnitine deficiency syndromes.
    Pons R; De Vivo DC
    J Child Neurol; 1995 Nov; 10 Suppl 2():S8-24. PubMed ID: 8576570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
    Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
    Treem WR; Rinaldo P; Hale DE; Stanley CA; Millington DS; Hyams JS; Jackson S; Turnbull DM
    Hepatology; 1994 Feb; 19(2):339-45. PubMed ID: 8294091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
    Fuda F; Narayan SB; Squires RH; Bennett MJ
    Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity and hepatotoxicity of 5,6-dichloro-4-thia-5-hexenoic acid: evidence for fatty acid beta-oxidation-dependent bioactivation.
    Fitzsimmons ME; Baggs RB; Anders MW
    J Pharmacol Exp Ther; 1994 Oct; 271(1):515-23. PubMed ID: 7965751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
    Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver.
    Ockner RK; Lysenko N; Manning JA; Monroe SE; Burnett DA
    J Clin Invest; 1980 May; 65(5):1013-23. PubMed ID: 7364935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
    Rubio-Gozalbo ME; Bakker JA; Waterham HR; Wanders RJ
    Mol Aspects Med; 2004; 25(5-6):521-32. PubMed ID: 15363639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.